IR415
IR415 is a potent anti-HBV agent and inhibits HBV replication by blocking the HBx activity. IR415 selectively interacts with HBx (Kd=2 nM) and blocks HBV-mediated RNAi suppression, reverses the inhibitory effect of HBx protein on the activity of the dicer endoribonuclease[1]. HBx: hepatitis B virus X protein.
Product Specifications
CAS Number
452967-14-5
UNSPSC
12352005
Target
HBV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/ir415.html
Purity
99.66
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
S=C(NCCCN1C=CN=C1)NC2=CC=C(F)C=C2F
Molecular Formula
C13H14F2N4S
Molecular Weight
296.34
References & Citations
[1]Ghosh S, et al. An RNAi-based high-throughput screening assay to identify small molecule inhibitors of hepatitis B virus replication.J Biol Chem. 2017 Jul 28;292 (30) :12577-12588.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY431638 100 µg
HSPC302 (TBCK) (NM_001163435) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC472505-100 1x 100 µL
CD73 (Immuno-Oncology Target) (NT5E/2505), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
